These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 3292967

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dextromethorphan reduces neocortical ischemic neuronal damage in vivo.
    George CP, Goldberg MP, Choi DW, Steinberg GK.
    Brain Res; 1988 Feb 09; 440(2):375-9. PubMed ID: 3359222
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Neuroprotection by N-methyl-D-aspartate antagonists in focal cerebral ischemia is dependent on continued maintenance dosing.
    Steinberg GK, Yoon EJ, Kunis DM, Sun GH, Maier CM, Grant GA.
    Neuroscience; 1995 Jan 09; 64(1):99-107. PubMed ID: 7708219
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Protection after transient focal cerebral ischemia by the N-methyl-D-aspartate antagonist dextrorphan is dependent upon plasma and brain levels.
    Steinberg GK, Kunis D, Saleh J, DeLaPaz R.
    J Cereb Blood Flow Metab; 1991 Nov 09; 11(6):1015-24. PubMed ID: 1939379
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Neuroprotection following focal cerebral ischaemia with the NMDA antagonist dextromethorphan, has a favourable dose response profile.
    Steinberg GK, Kunis D, DeLaPaz R, Poljak A.
    Neurol Res; 1993 Jun 09; 15(3):174-80. PubMed ID: 8103583
    [Abstract] [Full Text] [Related]

  • 13. Dextrorphan and dextromethorphan attenuate glutamate neurotoxicity.
    Choi DW.
    Brain Res; 1987 Feb 17; 403(2):333-6. PubMed ID: 2881608
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Selective depression of N-methyl-D-aspartate-mediated responses by dextrorphan in the hippocampal slice in rat.
    Cole AE, Eccles CU, Aryanpur JJ, Fisher RS.
    Neuropharmacology; 1989 Mar 17; 28(3):249-54. PubMed ID: 2657479
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Differential effects of morphinan drugs on haloperidol-induced catalepsy in rats: a comparative study with an N-methyl-D-aspartate antagonist.
    Scotti de Carolis A, Popoli P, Pezzola A, Sagratella S.
    Arch Int Pharmacodyn Ther; 1991 Mar 17; 310():132-41. PubMed ID: 1685312
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.